Las Vegas, USA, June 14, 2022 (GLOBE NEWSWIRE) — The Global Clot Management Devices Market To Advance Upto USD 2.2 Billion by 2027, Asserts DelveInsight
The Clot Management Devices market is anticipated to grow owing to several factors such as the increasing geriatric population who are the at-risk population for developing thrombus, rising prevalence of lifestyle disorders such as hypertension and obesity, and the innovation in product development leading to the development of second-generation thrombectomy devices.
DelveInsight’s Clot Management Devices Market Insights and Forecast report provides the current and forecasted Clot Management Devices, upcoming innovations in the devices, individual market shares of the devices, challenges, drivers, and barriers, market trends, and key competitors in the Clot Management Devices Market scenario.
Some of the key takeaways from the Clot Management Devices Market report:
- According to DelveInsight analysis, North America is expected to dominate the overall Global Clot Management Devices market during the forecasted period.
- Key Clot Management Devices companies proactively working in the market include Edward LifeSciences Corporation, Stryker, Johnson & Johnson, Medtronic, Penumbra, Microvention Inc., Terumo Corporation, Boston Scientific Inc, Abbott, Acandis GmbH, Perflow Medical Ltd, Koninklijke Philips N.V., phenox GmbH, AngioDynamics, ARGON MEDICAL, BD, B. Braun Melsungen AG, Cardinal Health.,…
